Page last updated: 2024-10-20

toluene and Parkinson Disease, Secondary

toluene has been researched along with Parkinson Disease, Secondary in 1 studies

methylbenzene : Any alkylbenzene that is benzene substituted with one or more methyl groups.

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cintra, A1
Andbjer, B1
Finnman, UB1
Hagman, M1
Agnati, LF1
Höglund, G1
Fuxe, K1

Other Studies

1 other study available for toluene and Parkinson Disease, Secondary

ArticleYear
Subacute toluene exposure increases DA dysfunction in the 6-OH dopamine lesioned nigrostriatal dopaminergic system of the rat.
    Neuroscience letters, 1996, Oct-11, Volume: 217, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Drug Administration Schedule; Dr

1996